Últimos Artículos de Terapeuthic Advances in Endocrinolgy and Metabolism
- Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?
- Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis
- Primary aldosteronism subtyping in the setting of partially successful adrenal vein sampling
- A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores
- Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitus
- The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
- The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol
- Insulin resistance in transgender individuals correlates with android fat mass
- Should metformin remain the first-line therapy for treatment of type 2 diabetes?
- Hypomagnesemia in persons with type 1 diabetes: associations with clinical parameters and oxidative stress
- Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control
- Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application
- Corrigendum to “Type 2 diabetes in older patients: an analysis of the DPV and DIVE databases”
- Corrigendum to “Assessment of Rwandan diabetic patients’ needs and expectations to develop their first diabetes self-management smartphone application (Kir’App)”
- Serum PTH levels in dialysis: better safe than sorry
- Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia
- The many-faced hurdle of cardiac involvement in diabetes: where to focus?
- The relation between serum adipose differentiation-related protein and non-alcoholic fatty liver disease in type 2 diabetes mellitus
- Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
- Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications